Bio-Rad Laboratories | BIO - Ebit

Stock Price
287.84
Daily Change
6.42 2.28%
Monthly
5.20%
Yearly
18.77%
Q2 Forecast
281.68

Bio-Rad Laboratories reported $-418.8M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Abbott USD 1.85B 684M Mar/2026
Agilent USD 353M 90M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bio Techne USD 54.46M 6.8M Dec/2025
Bio-Rad Laboratories USD -418.8M 845.4M Sep/2025
Bruker USD 76.3M 7.6M Dec/2025
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Danaher USD 1.34B 158M Mar/2026
General Electric Aerospace USD 2.09B 416M Mar/2026
Illumina USD 256M 6M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Laboratory Of America USD 382M 11M Dec/2025
Merck USD 6.24B 1.32B Dec/2025
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Myriad Genetics USD -3M 20.3M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quest Diagnostics USD 399M 13M Mar/2026
Repligen USD 19.97M 3.16M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Siemens EUR 2.57B 3M Dec/2025
Standard Biotools USD -21.92M 10.97M Dec/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Tosoh JPY 25.15B 3.51B Dec/2025
Waters USD 270.52M 78.4M Dec/2025